Metabolomics is the study of small compounds, often known as metabolites, in cells, biofluids, tissues, and organisms on a massive scale. The metabolome refers to the collection of small molecules and their interactions inside a biological system. Metabolomics, or the comprehensive examination of metabolites in a biological system, is a new technology that has the potential to revolutionise precision medicine. Small quantities of metabolites have traditionally been utilised to detect complex metabolic diseases as well as monogenic disorders such inborn metabolic abnormalities. Current metabolomic methods are capable of exact analysis of hundreds to thousands of metabolites, much exceeding the scope of typical clinical chemistry procedures. Metabolomics is a great tool for the pharmaceutical, preventative healthcare, and agricultural industries, among others, because of its non-invasive nature and close link to the phenotypic. We may be able to track the trends of our own metabolome for individualised medications and enhanced treatment techniques in the future, due to the availability of personalised metabolomics
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Phage Display-Based Biosensing for Rapid Detection of Neonatal Group B Streptococcal (GBS) Infection
Md Monir Hossain, RMIT University, Australia
Title : Contribution of bioengineered food in addressing hunger and food and nutrition security (FNS)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : An insight into sustainable practices in Environmental Biotechnology (EB)
Santosh Kumar Mishra , S.N.D.T. Women's University (Retired), India
Title : Lignocellulosic biomass to biofuels and biochemicals: Microbial innovations for a sustainable future
Gunjan Mukherjee, Chandigarh University, India